Cargando…
Biomarkers of Irritable Bowel Syndrome
Traditionally, irritable bowel syndrome (IBS) has not been regarded as an organic disease, and the pathophysiology of IBS is heterogeneous. Currently, the diagnosis of IBS is based upon the Rome diagnostic criteria. The performance of these criteria is only modest in predicting IBS, and moreover the...
Autores principales: | Kim, Jae Hak, Lin, Eugenia, Pimentel, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216630/ https://www.ncbi.nlm.nih.gov/pubmed/27817184 http://dx.doi.org/10.5056/jnm16135 |
Ejemplares similares
-
Serum biomarkers for irritable bowel syndrome
por: CHIRA, ALEXANDRA, et al.
Publicado: (2015) -
Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022) -
Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015) -
An Asian perspective on irritable bowel syndrome
por: Jung, Kee Wook, et al.
Publicado: (2023)